Clarity fuel
posted on
***** TODAY’S NEWS Busy days at Novartis: Licensing deal with Array for oncology drugs; major quarterly profit rise; buying up more generics with Oriel purchase; oral MS drug Gilenia draws closer …
Continue Reading about Impactiviti Daily 042010 Top Pharma News →
posted on
See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here. TODAY’S NEWS It's going …
posted on
Sales force efficiency (revenue generated per sales rep) measured and reported among 20 pharma companies - who do you think is on top? Plus, PWC issues a report with a keen grasp of the obvious about …
posted on
The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
posted on
Who needs exercise? Maybe we can get the benefits in a pill! - That dream, cherished by millions of sedentary couch potatoes, just got a little bit closer. Today, researchers are reporting that an …
posted on
After all that effort with alpha-blockers, beta-blockers, ACE inhibitors, etc....are we just going to circle back to diuretics?? Will Eli Lilly fork over $1,000,000,000 to make Zyprexa marketing …